- Open Access
Best practice guidelines for blunt cerebrovascular injury (BCVI)
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine volume 26, Article number: 90 (2018)
Blunt cerebrovascular injury (BCVI) is a non-penetrating injury to the carotid and/or vertebral artery that may cause stroke in trauma patients. Historically BCVI has been considered rare but more recent publications indicate an overall incidence of 1–2% in the in-hospital trauma population and as high as 9% in patients with severe head injury. The indications for screening, treatment and follow-up of these patients have been controversial for years with few clear recommendations. In an attempt to provide a clinically oriented guideline for the handling of BCVI patients a working committee was created. The current guideline is the end result of this committees work. It is based on a systematic literature search and critical review of all available publications in addition to a standardized consensus process. We recommend using the expanded Denver screening criteria and CT angiography (CTA) for the detection of BCVI. Early antithrombotic treatment should be commenced as soon as considered safe and continued for at least 3 months. A CTA at 7 days to confirm or discard the diagnosis as well as a final imaging control at 3 months should be performed.
Blunt cerebrovascular injury (BCVI) is a non-penetrating injury to the carotid and/or vertebral arteries. The pathological mechanism is thought to be stretching or impingement of the vessel walls as the head and neck is forcefully moved in flexion, extension or rotation. This causes intimal tear with exposure of subintimal layers to the blood flow and consequently thrombus formation, wall hematoma and even lumen occlusion. In some instances this process develops into a pseudoaneurysm . BCVI has been given considerable attention in the literature for the past 30 years [2,3,4,5]. It was earlier considered to be a very rare injury but recent publications show an incidence of 1–2% in the in-hospital trauma population and 9% in patients with severe head injury [6, 7]. BCVI is clearly associated with severe facial injuries and fractures of the skull base and cervical spine [8,9,10,11,12,13,14,15]. Thrombus formation at the site of an intimal tear may occlude the vessel or shed an emboli to a more peripheral brain artery, both processes resulting in a stroke. The true incidence of such an ischemic event due to BCVI is largely unknown, but reported in the range of 1–26% in recent literature [6, 16,17,18,19]. There seem to be a higher risk of ischemic events with injury to the carotid than the vertebral artery [19, 20]. BCVI is an independent predictor for poor outcome with higher morbidity and mortality rates in trauma patients with this injury, reported as high as 25–50% for those suffering a stroke [5, 19].Unfortunately, a substantial number of patients with this injury arrive at the hospital with a stroke in progress . Treating the remaining asymptomatic patients with BCVI in order to avoid an ischemic insult is controversial [17, 21, 22]. There have been numerous publications on the topic including systematic reviews. However, for the clinician working with trauma patients, the literature gives few specific recommendations that aid in the daily handling of this injury.
In this systematic review we raise the following clinical questions: 1. What part of the trauma population should be screened for BCVI? 2. Which radiological method should be applied for screening? 3. How should BCVI be treated? 4. How should patients with BCVI be handled over time? This is an attempt to provide «best practice» recommendations based on a systematic literature search, careful review of all available publications and methodical evaluation of the evidence.
An interdisciplinary working group consisting of five neurosurgeons (TB, ZO, MA, EH and BB), one anesthesiologists (SD) and one radiologist (KGM) was recruited through the Scandinavian Neurotrauma Committee (SNC-www.neurotrauma.nu). In addition, a research methodologist aided in the systematic evidence work (EJ). Key clinical questions were formulated according to the PICO model (Population, Intervention, Comparison and Outcome) (Table 1). All searches were limited to Scandinavian and English language sources. Initial searches were performed to identify existing guidelines in national databanks in each Scandinavian country (Prosedyrer i Nasjonalt nettverk for fagprosedyrer (NO), Nasjonale retningslinjer for Helsedirektoratet (NO), Socialstyrelsen, Nationella riktlinjer (SE) and Sundhedsstyrelsen (DK)) as well as UpToDate, National Guideline Clearinghouse, NICE guidelines and BMJ Best Practice. Systematic reviews where then inquired for through McMaster PLUS, Epistomonikos and The Cochrane Library. Systematic searches for primary articles with the aid of a research librarian were performed on February 11, 2016 with the mesh terms «carotid artery» and/or «vertebral artery», «injury» and/or «trauma» (Additional file 1). Primary studies were found in OVID medline, PubMed and Embase. The search was automated for OVID Medline and PubMed so that the final database included primary studies and systematic reviews through March 31, 2018. Titles were screened and abstracts read for all articles in English dealing with BCVI. Full text primary publications were read, critically reviewed and included if relevant and presenting own patient material. Case presentations with less than five patients were excluded. Grading the quality of evidence and strength of recommendations were conducted according to the GRADE approach . Evidence was rated as high, moderate, low or very low. Strength of recommendations was either strong or conditional. The final guidelines were evaluated in Oslo June 4, 2018 with collaborating medical doctors in a Delphi process utilizing the AGREE II instrument .
Our results and recommendations are summarized in Table 2. All recommendations apply to both adults and children. No recommendations in the national databanks were found. Two existing guidelines were found of which one was included (UpToDate) and the other found to be equivalent of an already included systematic review [25, 26] A total of 3198 titles were discovered through the remaining searches. Of these, nine systematic reviews were added to our database of which the work by Bromberg et al. was considered to be of particularly high methodological quality with clear clinical recommendations [26,27,28,29,30,31,32,33,34]. However, the search performed by Bromberg et al. ended in 2005 and all eligible papers published after this date were included. This resulted in a total of 78 articles composing our literature database for synthesis of the guidelines (Fig. 1 and Additional file 2). In general, the scientific evidence was found to be of low or moderate levels. Despite this, strength of recommendations were in some instances set as «strong» as the potential benefits were considered to outweigh possible risk factors. This guideline is an update of existing recommendations with a focus on advising the clinician in handling the trauma patient with BCVI.
Clinical question 1: What part of the trauma population should be screened for BCVI?
All hospitals dealing with a general trauma population should have a systematic and evaluated set of screening criteria in order to assess patients for BCVI. Of existing screening tools we recommend the expanded Denver screening criteria for both adults and children (Table 3). These criteria apply to trauma patients with signs or symptoms of BCVI or a high-energy trauma mechanism with one or more of the risk factors listed in Table 3.
Strength of recommendations: Strong.
Level of evidence: Low.
Evidence and rationale
In 1998 Biffl et al. demonstrated that screening could identify asymptomatic patients with BCVI . Other groups have presented similar works [36, 37]. It has been estimated that even with such screening criteria as many as 20% of patients with BCVI may go undetected due to the heterogeneity inherent to this population and the imperfectness of screening tools [37, 38]. However, studies have shown that focus on this condition in a trauma setting and implementation of standardized handling increases the detection rate and may even decrease stroke rate through earlier imaging and treatment [19, 34, 39,40,41,42,43,44,45]. Even though no direct comparative studies examining the diagnostic yield of each screening tool exist, the work by Biffl et al. is probably the most extensive and best evaluated [38, 40, 43, 46]. Later known as the Denver screening criteria this clinical tool focus on signs and symptoms of BCVI as well as specific risk factors associated with a high-energy transfer mechanism . It incorporates all indicators also applied by the so-called Memphis screening tool [47, 48]. In the most recent version of the Denver criteria several new risk factors for BCVI has been identified and the expanded screening criteria now includes all patients with cervical spine fractures . This development is supported by others including a meta-analysis demonstrating a 5-times greater likelihood of BCVI in trauma patients with cervical spine fractures compared to those without . In our Delphi consensus meeting such a liberal screening policy was discussed and met with criticism for risk of over-triage and unnecessary radiation exposure. There is a clear need for further studies investigating the diagnostic yield of CTA with the expanded Denver screening criteria and whether they alter patient management or reduce the stroke rate in trauma patients.
Several authors have demonstrated that BCVI do occur in traumatized children and that the incidence may be as high as in adults [28, 50, 51]. An attempt to create a pediatric screening tool in order to minimize the use of radiation exposure from CT angiography (CTA) has also been made [52, 53]. However, in a retrospective study on 7440 pediatric trauma admissions this so called Utah-score failed to accomplish the same detection rate as the Denver screening criteria and other authors have recommended that pediatric trauma patients are managed as adults with respect to imaging for BCVI [54, 55]. In a recent report by Herbert et al. the Utah score was further developed by adding an analysis of the mechanism of injury defining high-risk groups in pediatric trauma patients . Though the authors claim that this adds an improved detection rate compared to both the Denver and Memphis screening tools the difference is in our opinion not clinically relevant.
Clinical question 2: Which radiological method should be applied for screening?
A CT angiography (CTA) of the precerebral carotid and vertebral arteries extending through the base of the skull and including the circle of Willis should be performed in those patients meeting one or more of the Denver screening criteria. A minimum of 16-channel CT technology should be applied. If discovered, vessel injury should be classified according to the Biffl injury grading scale (Table 4).
Strength of recommendations: Strong.
Level of evidence: Moderate.
Evidence and rationale
Digital subtraction angiography (DSA) still remains the gold standard in detecting BCVI [32, 37, 57, 58]. However, this technique is time consuming and not offered by all institutions as a full-time, 7-days a week service. DSA carries a higher risk of procedure-related complications than CTA such as stroke, pseudoaneurysm and hematoma at the site of vessel puncture [59, 60]. In a meta-analysis of CTA versus DSA in BCVI diagnosis it was demonstrated a great variation in published sensitivity and specificity for CTA . The demonstrated pooled sensitivity and specificity for BCVI detection with CTA were 66% and 97%, respectively. This was possibly due to variations in diagnostic threshold and experience across the respective trauma institutions. There seem to be a clear correlation between improved CT technology and diagnostic accuracy: Modern CT scanners with 16-, 32- and 64 -channel technology demonstrate higher sensitivity and specificity with increasing number of slices per rotation [58, 59, 61,62,63]. In a cost-effectiveness study by Malhotra et al. CTA was found to be superior to DSA in patients selected for imaging based on the Denver screening criteria . Eastman and co-workers significantly reduced time from injury to diagnosis of BCVI from 31.2 h to 2.65 h when converting from DSA to CTA. The stroke rate was also significantly reduced from 15.2 to 3.8%. As medical therapy before and after CTA implementation remained the same, this reduction in ischemic events have been attributed to earlier start of treatment .
There seem to be a consistent finding that CTA may detect almost all clinically significant BCVIs as very few strokes have been observed in trauma patients with a negative CTA [57, 59, 61, 62, 64, 65]. DSA is in our opinion impractical as a primary imaging tool as the expanded clinical screening criteria now make more patients eligible for imaging.
Even though MRI technology and availability have greatly improved over the past years few studies using MR angiography for BCVI have been performed. Though the technique may offer comparable sensitivity and specificity as that of CTA it remains impractical and time consuming as a screening tool for the multi-traumatized patient. Ultrasound is observer-dependent and visualizing the entire vertebral artery is challenging .
When BCVI is detected, we recommend the use of a grading scale for prognostication and comparison with repeated imaging (Table 4). The so-called Biffl injury grading scale has been extensively used and demonstrate a good intra -and interrater reliability .
Clinical question 3: How should BCVI be treated?
Antithrombotic therapy should be initiated as soon as considered safe. Early antithrombotic therapy may be commenced even in the setting of severe head injury or other solid organ injury.
Strength of recommendation: Strong.
Level of evidence: Low.
Treatment may consist of anti-platelet or anti-coagulation therapy. We recommend initiation of low-molecular weight heparin (LMWH) in antithrombotic doses within 24–48 h of the diagnosis followed by transfer to oral acetyl salicylic acid (ASA) 75 mg daily when appropriate. In pediatric cases, 3–5 mg/kg of ASA is recommended. The treatment should be continued for at least 3 months (Fig. 2).
Strength of recommendation: Strong.
Level of evidence: Low.
For pseudoaneurysms progressing in size or severe luminal stenosis producing thrombotic and/or ischemic events a neurointerventionist with endovascular expertise should be consulted.
Strength of recommendation: Conditional.
Level of evidence: Low.
Evidence and rationale
Historically, BCVI was often retrospectively detected in the setting of stroke in a trauma patient. With the introduction of screening criteria and non-invasive diagnostics the incidence of asymptomatic BCVI has increased . This has made medical intervention possible in hopes that an ischemic event may be avoided. However, treatment effects with respect to stroke rates vary between studies and the results are conflicting. [17,18,19, 21, 22, 43, 68, 69]. Possible benefits of antithrombotic treatment must be weighed against any potential risks such as worsening of intracranial hemorrhage or existing hematomas in other solid organs as these patients often have multiple injuries. However, recent studies on BCVI and concomitant intracranial, intraspinal or solid organ injuries have shown no difference in hemorrhagic worsening between treated or untreated patients [7, 43, 68, 70, 71].
Based on the existing literature it is difficult to clearly decide whether treatment of patients with BCVI make a clinically significant difference. This is due to the retrospective nature and small sample sizes of the publications, lack of randomized studies and poorly defined criteria for diagnosing a stroke in this heterogeneous trauma population. On the other hand, knowing that stroke may appear as early as minutes after the injury and as late as days and even weeks it seems rational to recommend early onset of treatment in order to prevent an ischemic event . Eastman et al. demonstrated a reduced stroke rate from 15.3 to 3.8% when time to diagnosis and thus start of treatment was lowered . A recommendation of early treatment is in accordance with existing guidelines constituted from older primary studies than those included in our work [26, 27, 29, 31, 34, 72]. While earlier studies utilized systemic heparin infusion, more recent work has examined the use of oral antiplatelet or LMWH [7, 19, 43]. No randomized study has been performed comparing antiplatelet to anticoagulation in BCVI patients. Various publications show that several different treatment plans have been deployed often at the discretion of the attending physicians and that no drug has proven more effective than others [19, 73, 74]. There is no evidence that double platelet inihibitors or a combination of drugs is more effective than a single-drug regimen .
In a randomized study on spontaneous dissections of vertebral and carotid arteries it was found an equivalence of treatment result between antiplatelet and anticoagulation regimens . As systemic heparinization is more labor-demanding than LMWH through the need of monitoring (aPTT or antifactor Xa heparin assay) we recommend the use of LMWH for the initial treatment. Systemic heparinization has previously been associated with increased risk of hemorrhage in the trauma population . LMWH has a relatively short half-life of approximately 12 h and may be partially reversed by the use of protamine sulphate in case of hemorrhagic complications or pending surgical treatment . LMWH may be continued throughout the entire treatment period, but oral antiplatelets should be used if feasible. We recommend low dose ASA (75 mg × 1) as this oral antiplatelet is readily available, cheap, easily administered even in children and as effective as a higher dose ASA in stroke prevention [50, 68, 79].
A strong recommendations as to exact length of treatment cannot be made. In a retrospective study on 29 patients, Rao et al. found that mean time to luminal recovery in patients with spontaneous and traumatic carotid dissections was 11.2 months . Others have suggested that cervical vessel injuries that resolve do so within 3–6 months indicating that this may be sufficient for most patients [76, 81]. There is a paucity of data and most studies with long-term follow-up are on patients with spontaneous dissections. Luminal stenosis from atherosclerotic plaques represent a clinically different setting than that seen in trauma patients with persistent vessel narrowing.Whether a remaining vessel narrowing after 3–6 months in an asymptomatic trauma patient represent an indication for continued medical treatment or endovascular intervention is undetermined.
Endovascular treatment of BCVI has evolved over the past 20 years but remains controversial as complication rates, stent patency and stroke rates vary [30, 74, 82,83,84]. A pseudoaneurysm represents a vascular area with reduced flow and potential clot formation. Patients with this type of BCVI have often been considered candidates for endovascular intervention as the aneurysms rarely disappear and may produce cerebral emboli [69, 85]. Grade IV injuries (vessel occlusion) have also been suggested as indication for intervention in order to avoid recanalization and embolic events . However, the need for double platelet treatment after stent placement is problematic in trauma patients. The current literature is divergent and inconclusive thus making clinical recommendations difficult. Each institution should consider its own experience with this technique and tailor any endovascular procedures in BCVI patients accordingly.
Clinical question 4: How should patients with vessel injury be handled over time?
A follow-up CTA after approximately 7 days and 3 months is recommended. Strength of recommendation: Conditional.
Level of evidence: Low.
Evidence and rationale
As CTA may display false-positive findings we recommend a repeat scan after approximately 7 days. This may confirm the diagnosis and strengthen the indication for continued treatment or rule out the diagnosis in cases where the initial CTA was misinterpreted or displayed vessel spasm . In the latter situations treatment may be halted. This recommendation is in accordance with previous guidelines [27, 72].
Follow-up studies on BCVI patients are few but seem to indicate that healing of the vessel lesion is reversely associated with injury grade: The higher Biffl injury grade (III and IV) lesions are less likely to improve than the low grades . In a study of 110 patients with blunt carotid injuries, angiographic follow-up at a mean of 6 months was available in 50 patients demonstrating stable or improved findings in 75% of cases . Franz et al. re-imaged 17 of 29 patients with BCVI with complete resolution in 84% at a mean of 9.2 weeks . A final CTA after 3 months may thus serve as a guide for the clinician in deciding whether to continue or end antithrombotic treatment.
The current guideline recommends using the expanded Denver screening criteria and CTA for the detection of BCVI in the in-hospital trauma population. Early antithrombotic treatment should be commenced as soon as considered safe and continued for at least 3 months when BCVI is detected. A follow-up CTA after approximately 7 days is recommended in order to confirm or reject the diagnosis. A final imaging at 3 months may serve as guidance for further individual treatment. There is an obvious need for more studies providing better data regarding incidence, yield of screening criteria, stroke rates and long term results. We encourage other institutions to address these issues and suggest utilizing results from trauma databases or through prospective studies.
- AGREE II:
Appraisal of guidelines for research and evaluation
Acetyl salicylic acid
Blunt cerebrovascular injury
Computed tomography angiography
Digital subtraction angiography
Grading of recommendations, assessment, development and evaluations
Low-molecular weight heparin
Biffl WL, Moore EE, Offner PJ, Burch JM. Blunt carotid and vertebral Arterial Injuries. World J Surg. 2001;25:1036–43.
Blickenstaff KL, Weaver FA, Yellin AE, et al. Trends in the management of traumatic vertebral artery injuries. Am J Surg. 1989;158:101–6.
Rogers FB, Baker EF, Osler TM, et al. Computed tomographic angiography as a screening modality for blunt cervical arterial injuries. J Trauma Inj Infect Crit Care. 1999;46:380–5.
Laser A, Kufera J, Bruns BR, et al. Initial screening test for blunt cerebrovascular injury: validity assessment of whole-body computed tomography. Surgery. 2015;158:627–35.
Schicho A, Luerken L, Meier R, et al. Incidence of traumatic carotid and vertebral artery dissections: results of cervical vessel computed tomography angiogram as a mandatory scan component in severely injured patients. Ther Clin Risk Manag. 2018;14:173–8.
Weber CD, Lefering R, Kobbe P, et al. Blunt cerebrovascular artery injury and stroke in severely injured patients: an international multicenter analysis. World J Surg. 2017;30:15.
Esnault P, Cardinale M, Boret H, et al. Blunt cerebrovascular injuries in severe traumatic brain injury: incidence, risk factors, and evolution. J Neurosurg. 2017;127:16–22.
Sun GH, Shoman NM, Samy RN, Pensak ML. Analysis of carotid artery injury in patients with basilar skull fractures. Otol Neurotol. 2011;32:882–6.
Kopelman TR, Leeds S, Berardoni NE, et al. Incidence of blunt cerebrovascular injury in low-risk cervical spine fractures. Am J Surg. 2011;202:684–9.
Lebl DR, Bono CM, Velmahos G, et al. Vertebral artery injury associated with blunt cervical spine trauma: a multivariate regression analysis. Spine. 2013;38:1352–61.
Ding T, Maltenfort M, Yang H, et al. Correlation of C2 fractures and vertebral artery injury. Spine. 2010;35:E520–4.
Cothren CC, Moore EE, Biffl WL, et al. Anticoagulation is the gold standard therapy for blunt carotid injuries to reduce stroke rate. Arch Surg. 2004;139:540–6.
Durand D, Wu X, Kalra VB, et al. Predictors of vertebral artery injury in isolated C2 fractures based on fracture morphology using CT angiography. Spine. 2015;40:E713–8.
Mundinger GS, Dorafshar AH, Gilson MM, et al. Blunt-mechanism facial fracture patterns associated with internal carotid artery injuries: recommendations for additional screening criteria based on analysis of 4,398 patients. J Maxillofac Oral Surg. 2013;71:2092–100.
McKinney A, Ott F, Short J, McKinney Z, Truwit C. Angiographic frequency of blunt cerebrovascular injury in patients with carotid canal or vertebral foramen fractures on multidetector CT. Eur J Radiol. 2007;62:385–93.
Mueller C-A, Peters I, Podlogar M, et al. Vertebral artery injuries following cervical spine trauma: a prospective observational study. Eur Spine J. 2011;20:2202–9.
Scott WW, Sharp S, Figueroa SA, et al. Clinical and radiographic outcomes following traumatic grade 1 and 2 carotid artery injuries: a 10-year retrospective analysis from a Level-1 trauma center. The parkland carotid and vertebral artery injury survey. J Neurosurg. 2015;122:1196–201.
Lockwood MA, Tanenbaum J, Lubelski D, Erratum SA. Screening via CT angiogram after traumatic cervical spine fractures: narrowing imaging to improve cost effectiveness. Experience of a level I trauma center. J Neurosurg Spine. 2016;24:490–5.
Stein DM, Boswell S, Sliker CW, et al. Blunt cerebrovascular injuries: does treatment always matter? J Trauma. 2009;66:132–44.
Crawford JD, Allan KM, Patel KU, et al. The natural history of indeterminate blunt cerebrovascular injury. JAMA Surg. 2015;150:841–7.
Scott WW, Sharp S, Figueroa SA, Eastman AL, Hatchette CV, Madden CJ, et al. Clinical and radiographic outcomes following traumatic grade 3 and 4 carotid artery injuries: a 10-year retrospective analysis from a level 1 trauma center. The parkland carotid and vertebral artery injury survey. J Neurosurg. 2015;122:610–5.
Spaniolas K, Velmahos GC, Alam HB, et al. Does improved detection of blunt vertebral artery injuries lead to improved outcomes? Analysis of the National Trauma Data Bank. World J Surg. 2008;32:2190–4.
Kerwin AJ, Haut ER, Burns JB, et al. The eastern Association of the Surgery of trauma approach to practice management guideline development using grading of recommendations, assessment, development, and evaluation (GRADE) methodology. J Trauma Acute Care Surg. 2012;73:S283–7.
Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182:E839–42.
Biffl WL, Burlew CC, Moore EE. Blunt cerebrovascular injury: treatment and outcomes. UpToDate 2018.
Harrigan MR, Hadley MN, Dhall SS, et al. Management of vertebral artery injuries following non-penetrating cervical trauma. Neurosurgery. 2013;72:234–43.
Bromberg WJ, Collier BC, Diebel LN, et al. Blunt cerebrovascular injury practice management guidelines: the eastern Association for the Surgery of trauma. J Trauma. 2010;68:471–7.
Chamoun RB, Mawad ME, Whitehead WE, et al. Extracranial traumatic carotid artery dissections in children: a review of current diagnosis and treatment options. J Neurosurg Pediatr. 2008;2:101–8.
de Souza RM, Crocker MJ, Haliasos N, et al. Blunt traumatic vertebral artery injury: a clinical review. Eur Spine J. 2011;20:1405–16.
DuBose J, Recinos G, Teixeira PGR, et al. Endovascular stenting for the treatment of traumatic internal carotid injuries: expanding experience. J Trauma. 2008;65:1561–6.
Fassett DR, Dailey AT, Vaccaro AR. Vertebral artery injuries associated with cervical spine injuries: a review of the literature. J Spinal Disord Tech. 2008;21:252–8.
Malhotra AK, Camacho M, Ivatury RR, et al. Computed tomographic angiography for the diagnosis of blunt carotid/vertebral artery injury: a note of caution. Ann Surg. 2007;246:632–43.
Roberts DJ, Chaubey VP, Zygun DA, et al. Diagnostic accuracy of computed tomographic angiography for blunt cerebrovascular injury detection in trauma patients: a systematic review and meta-analysis. Ann Surg. 2013;257:621–32.
Shafafy R, Suresh S, Afolayan JO, et al. Blunt vertebral vascular injury in trauma patients: ATLS® recommendations and review of current evidence. J Spine Surg. 2017;3:217–25.
Biffl WL, Moore EE, Ryu RK, et al. The unrecognized epidemic of blunt carotid and arterial injury. Ann Surg. 1998;228:462–70.
Berne JD, Norwood SH. Blunt vertebral artery injuries in the era of computed tomographic angiographic screening: incidence and outcomes from 8,292 patients. J Trauma. 2009;67:1333–8.
Emmett KP, Fabian TC, DiCocco JM, et al. Improving the screening criteria for blunt cerebrovascular injury: the appropriate role for computed tomography angiography. J Trauma. 2011;70:1058–63.
Burlew CC, Biffl WL, Moore EE, et al. Blunt cerebrovascular injuries: redefining screening criteria in the era of noninvasive diagnosis. J Trauma Acute Care Surg. 2012;72:330–7.
Löhrer L, Vieth V, Nassenstein I, et al. Blunt cerebrovascular injuries in acute trauma care: a screening protocol. Eur Spine J. 2011;21:837–43.
Geddes AE, Burlew CC, Wagenaar AE, et al. Expanded screening criteria for blunt cerebrovascular injury: a bigger impact than anticipated. Am J Surg. 2016;212:1167–74.
Hoit DA, Schirmer CM, Weller SJ, et al. Angiographic detection of carotid and vertebral arterial injury in the high-energy blunt trauma patient. J Spinal Disord Tech. 2008;21:259–66.
Malhotra A, Wu X, Kalra VB, et al. Evaluation for blunt cerebrovascular injury: review of the literature and a cost-effectiveness analysis. AJNR Am J Neuroradiol. 2016;37:330–5.
Tso MK, Lee MM, Ball CG, et al. Clinical utility of a screening protocol for blunt cerebrovascular injury using computed tomography angiography. J Neurosurg. 2017;126:1033–41.
Sinnathamby M, Rao SV, Weber DG. Increased detection of blunt carotid and vertebral artery injury after implementation of diagnostic imaging pathway in level 1 trauma Centre in Western Australia. Injury. 2017;48:1917–21.
Eastman AL, Muraliraj V, Sperry JL, Minei JP. CTA-based screening reduces time to diagnosis and stroke rate in blunt cervical vascular injury. J Trauma. 2009;67:551–6.
Beliaev AM, Barber PA, Marshall RJ, Civil I. Denver screening protocol for blunt cerebrovascular injury reduces the use of multi-detector computed tomography angiography. ANZ J Surg. 2013;84:429–32.
Miller PR, Fabian TC, Bee TK, et al. Blunt cerebrovascular injuries: diagnosis and treatment. J Trauma. 2001;51:279–86.
Ciapetti M, Circelli A, Zagli G, et al. Diagnosis of carotid arterial injury in major trauma using a modification of Memphis criteria. Scand J trauma, Resusc Emerg Med. 2010;18:1–5.
Franz RW, Willette PA, Wood MJ, et al. A systematic review and meta-analysis of diagnostic screening criteria for blunt cerebrovascular injuries. J Am Coll Surg. 2012;214:313–27.
Tolhurst SR, Vanderhave KL, Caird MS, et al. Cervical arterial injury after blunt trauma in children: characterization and advanced imaging. J Pediatr Orthop. 2013;33:37–42.
Jones TS, Burlew CC, Kornblith LZ, et al. Blunt cerebrovascular injuries in the child. Am J Surg. 2012;204:7–10.
Ravindra VM, Riva-Cambrin J, Sivakumar W, et al. Risk factors for traumatic blunt cerebrovascular injury diagnosed by computed tomography angiography in the pediatric population: a retrospective cohort study. J Neurosurg Pediatr. 2015;15:599–606.
Ravindra VM, Bollo RJ, Sivakumar W, et al. Predicting blunt cerebrovascular injury in pediatric trauma: validation of the “Utah score”. J Neurotrauma. 2017;34:391–9.
Azarakhsh N, Grimes S, Notrica DM, et al. Blunt cerebrovascular injury in children: underreported or underrecognized?: A multicenter ATOMAC study. J Trauma Acute Care Surg. 2013;75:1006–12.
Kopelman TR, Berardoni NE, OʼNeill PJ, et al. Risk factors for blunt cerebrovascular injury in children: do they mimic those seen in adults? J Trauma Inj Infect Crit Care. 2011;71:559–64.
Herbert JP, Venkataraman SS, Turkmani AH, et al. Pediatric blunt cerebrovascular injury: the McGovern screening score. J Neurosurg Pediatr. 2018;21:1–11.
Shahan CP, Magnotti LJ, Stickley SM, et al. A safe and effective management strategy for blunt cerebrovascular injury: avoiding unnecessary anticoagulation and eliminating stroke. J Trauma Acute Care Surg. 2016;80:915–22.
Goodwin RB, Beery PR, Dorbish RJ, et al. Computed tomographic angiography versus conventional angiography for the diagnosis of blunt cerebrovascular injury in trauma patients. J Trauma. 2009;67:1046–50.
Paulus EM, Fabian TC, Savage SA, et al. Blunt cerebrovascular injury screening with 64-channel multidetector computed tomography. J Trauma Acute Care Surg. 2014;76:279–85.
Willinsky RA, Taylor SM, terBrugge K, et al. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology. 2003;227:522–8.
Berne JD, Reuland KS, Villarreal DH, et al. Sixteen-slice multi-detector computed tomographic angiography improves the accuracy of screening for blunt cerebrovascular injury. J Trauma Inj Infect Crit Care. 2006;60:1204–10.
Payabvash S, McKinney AM, McKinney ZJ, et al. Screening and detection of blunt vertebral artery injury in patients with upper cervical fractures: the role of cervical CT and CT angiography. Eur J Radiol. 2014;83:571–7.
Eastman AL, Chason DP, Perez CL, et al. Computed tomographic angiography for the diagnosis of blunt cervical vascular injury: is it ready for primetime? J Trauma Inj Infect Crit Care. 2006;60:925–9.
Utter GH, Hollingworth W, Hallam DK, et al. Sixteen-slice CT angiography in patients with suspected blunt carotid and vertebral artery injuries. J Am Coll Surg. 2006;203:838–48.
Schneidereit NP, Simons R, Nicolaou S, et al. Utility of screening for blunt vascular neck injuries with computed tomographic angiography. J Trauma Inj Infect Crit Care. 2006;60:209–15.
Nagpal P, Policeni BA, Bathla G, et al. Blunt cerebrovascular injuries: advances in screening, imaging, and management trends. AJNR Am J Neuroradiol. 2017;75:543–9.
Foreman PM, Griessenauer CJ, Kicielinski KP, et al. Reliability assessment of the Biffl scale for blunt traumatic cerebrovascular injury as detected on computer tomography angiography. J Neurosurg. 2017;127:32–5.
Callcut RA, Hanseman DJ, Solan PD, et al. Early treatment of blunt cerebrovascular injury with concomitant hemorrhagic neurologic injury is safe and effective. J Trauma Inj Infect Crit Care. 2012;72:338–46.
Wagenaar AE, Burlew CC, Biffl WL, et al. Early repeat imaging is not warranted for high-grade blunt cerebrovascular injuries. J Trauma Acute Care Surg. 2014;77:540–5.
Shahan CP, Magnotti LJ, McBeth PB, et al. Early antithrombotic therapy is safe and effective in patients with blunt cerebrovascular injury and solid organ injury or traumatic brain injury. J Trauma Acute Care Surg. 2016;81:173–7.
McNutt MK, Kale AC, Kitagawa RS, et al. Management of blunt cerebrovascular injury (BCVI) in the multisystem injury patient with contraindications to immediate anti-thrombotic therapy. Injury. 2018;49:67–74.
Biffl WL, Cothren CC, Moore EE, et al. Western trauma association critical decisions in trauma: screening for and treatment of blunt cerebrovascular injuries. J Trauma. 2009;67:1150–3.
Alterman DM, Heidel RE, Daley BJ, et al. Contemporary outcomes of vertebral artery injury. J Vasc Surg. 2013;57:741–6.
Edwards NM, Fabian TC, Claridge JA, et al. Antithrombotic therapy and endovascular stents are effective treatment for blunt carotid injuries: results from longterm followup. J Am Coll Surg. 2007;204:1007–15.
Daou B, Hammer C, Mouchtouris N, et al. Anticoagulation vs antiplatelet treatment in patients with carotid and vertebral artery dissection: a study of 370 patients and literature review. Neurosurgery. 2017;80:368–79.
Markus HS, Hayter E, Levi C, Feldman A, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14:361–7.
Wahl WL, Brandt M-M, Thompson BG, et al. Antiplatelet therapy: an alternative to heparin for blunt carotid injury. J Trauma Inj Infect Crit Care. 2002;52:896–901.
Dhakal P, Rayamajhi S, Verma V, et al. Reversal of anticoagulation and management of bleeding in patients on anticoagulants. Clin Appl Thromb Hemost. 2016;23:410–5.
Leys D, Balucani C, Cordonnier C. Antiplatelet drugs for ischemic stroke prevention. Cerebrovasc Dis. 2009;27:120–5.
Rao AS, Makaroun MS, Marone LK, et al. Long-term outcomes of internal carotid artery dissection. J Vasc Surg. 2011;54:370–5.
Nedeltchev K, Bickel S, Arnold M, et al. Recanalization of spontaneous carotid artery dissection. Stroke. 2009;40:499–504.
Chen PR, Edwards NJ, Sanzgiri A, Day AL. Efficacy of a self-expandable porous stent as the sole curative treatment for extracranial carotid pseudoaneurysms. World Neurosurg. 2016;88:333–41.
Herrera DA, Vargas SA, Dublin AB. Endovascular treatment of traumatic injuries of the vertebral artery. AJNR Am J Neuroradiol. 2008;29:1585–9.
Burlew CC, Biffl WL, Moore EE, et al. Endovascular stenting is rarely necessary for the management of blunt cerebrovascular injuries. J Am Coll Surg. 2014;218:1012–7.
Mei Q, Sui M, Xiao W, et al. Individualized endovascular treatment of high-grade traumatic vertebral artery injury. Acta Neurochir. 2014;156:1781–8.
Lauerman MH, Feeney T, Sliker CW, et al. Lethal now or lethal later: the natural history of grade 4 blunt cerebrovascular injury. J Trauma Acute Care Surg. 2015;78:1071–4.
Franz RW, Goodwin RB, Beery PR, et al. Postdischarge outcomes of blunt cerebrovascular injuries. Vasc Endovasc Surg. 2010;44:198–211.
Anita Saur Haukvik, research librarian at the medical library of Sørlandet Hospital Kristiansand, Norway performed the systematic searches in the various databases. Inger Marie Drage (Pediatric anesthesiologist, Oslo University Hospital Ullevål, Oslo, Norway), Jørgen Joakimsen (Vascular surgeon, Oslo University Hospital Ullevål, Oslo, Norway), Annette Robertsen (Intensive care anesthesiologist, Oslo University Hospital Ullevål, Oslo, Norway) and Ruth Sletteberg (Neurointerventionist, Oslo University Hospital Rikshospitalet, Oslo, Norway) for participating in the Delphi meeting held in Oslo June 4, 2018.
Availability of data and materials
Ethics approval and consent to participate
Not applicable as this is a systematic review based on published literature.
Consent for publication
Not applicable as this is a systematic review.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.